Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Smoking Cessation for People With HIV/AIDS
NCT02460900Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by University of Maryland, Baltimore. Started Jul 2016; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02460900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460900.